Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT Analysis Review

Date: May 15, 2014
Pages: 41
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: Q7180A8842CEN
Leaflet:

Download PDF Leaflet

Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT Analysis Review
Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Quintiles Transnational Holdings Inc. (Quintiles) is one of the largest contract research organizations and a provider of biopharmaceutical services. It caters to the needs of biopharmaceutical companies and other healthcare organizations including payers and providers. The company’s service portfolio includes clinical trials, product development services and integrated healthcare services. Quintiles conducts clinical trials on behalf of its clients and provides clinical trial management services; and helps optimize drug development.

Quintiles Transnational Holdings Inc. Key Recent Developments

May 01, 2014: Quintiles Reports First Quarter 2014 Results
Feb 13, 2014: Quintiles Reports Fourth Quarter 2013 Results
Jan 07, 2014: Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th
Dec 17, 2013: Richard Relyea Elected to the Quintiles Transnational Holdings Board of Directors
Oct 31, 2013: Quintiles President & COO John Ratliff to Leave Company at End of 2013

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Quintiles Transnational Holdings Inc. - Key Facts
Quintiles Transnational Holdings Inc. - Key Employees
Quintiles Transnational Holdings Inc. - Key Employee Biographies
Quintiles Transnational Holdings Inc. - Major Products and Services
Quintiles Transnational Holdings Inc. - History
Quintiles Transnational Holdings Inc. - Company Statement
Quintiles Transnational Holdings Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Quintiles Transnational Holdings Inc. - Business Description
Quintiles Transnational Holdings Inc. - Corporate Strategy
Quintiles Transnational Holdings Inc. - SWOT Analysis
SWOT Analysis - Overview
Quintiles Transnational Holdings Inc. - Strengths
Strength - Consistent Growth in Revenue
Strength - Extensive Range of Pharmaceutical Services
Strength - Wide Geographical Base
Quintiles Transnational Holdings Inc. - Weaknesses
Weakness - Legal Issues
Weakness - Therapeutic and Customer Concentration
Quintiles Transnational Holdings Inc. - Opportunities
Opportunity - Industry Recognition
Opportunity - Acquisitions-Growth Opportunity
Opportunity - Strategic Collaborations and Agreements
Quintiles Transnational Holdings Inc. - Threats
Threat - Competitive Environment
Threat - Stringent Government Regulations
Quintiles Transnational Holdings Inc. - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Quintiles Transnational Holdings Inc., Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Quintiles Transnational Holdings Inc., Recent Developments
May 01, 2014: Quintiles Reports First Quarter 2014 Results
Feb 13, 2014: Quintiles Reports Fourth Quarter 2013 Results
Jan 07, 2014: Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th
Dec 17, 2013: Richard Relyea Elected to the Quintiles Transnational Holdings Board of Directors
Oct 31, 2013: Quintiles President & COO John Ratliff to Leave Company at End of 2013
Oct 31, 2013: Quintiles Reports Third Quarter 2013 Results
Oct 01, 2013: Quintiles’ Third Quarter 2013 Earnings Call Scheduled for Thursday, October 31st
Aug 01, 2013: Quintiles Reports Second Quarter 2013 Results and Full Year 2013 Guidance
Jul 01, 2013: Quintiles’ Second Quarter 2013 Earnings Call Scheduled for Thursday, August 1st
May 15, 2013: Merck Serono And Quintiles Announce Innovative Clinical Development Partnership

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Quintiles Transnational Holdings Inc., Key Facts
Quintiles Transnational Holdings Inc., Key Employees
Quintiles Transnational Holdings Inc., Key Employee Biographies
Quintiles Transnational Holdings Inc., Major Products and Services
Quintiles Transnational Holdings Inc., History
Quintiles Transnational Holdings Inc., Other Locations
Quintiles Transnational Holdings Inc., Subsidiaries
Quintiles Transnational Holdings Inc., Key Competitors
Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Quintiles Transnational Holdings Inc., Recent Deals Summary

LIST OF FIGURES

Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: